Foster & Motley Inc Moderna, Inc. Transaction History

Foster & Motley Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$118.38 - $210.04 $251,202 - $445,704	-2,122 Reduced 46.75%	2,417 $434,000
Q3 2022 Nov 04, 2022	BUY	$118.07 - $194.18 $171,909 - $282,726	1,456 Added 47.23%	4,539 $537,000
Q2 2022 Aug 09, 2022	SELL	$117.13 - $176.59 $552,033 - $832,268	-4,713 Reduced 60.45%	3,083 $440,000
Q1 2022 Apr 28, 2022	BUY	$126.46 - $235.05 $512,542 - $952,657	4,053 Added 108.28%	7,796 $1.34 Million
Q4 2021 Jan 25, 2022	BUY	$225.82 - $368.51 $845,244 - $1.38 Million	3,743 New	3,743 $951,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Foster & Motley Inc, based on Form 13F filings with the SEC.

Stay updated on Foster & Motley Inc with notifications on news.